Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03402139 · ClinicalTrials.gov registry record

Early Childhood Obesity Programming by Intrauterine Growth Restriction

A clinical trial of Childhood Obesity and Epigenetics, sponsored by Montefiore Medical Center.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT03402139 is a study of Childhood Obesity and Epigenetics that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 400 participants, below the 551-participant average among 43 other Childhood Obesity trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03402139, a study of Childhood Obesity and Epigenetics, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life.

Study Locations (1)

New York

  • Jack D. Weiler Hospital - The Bronx

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2018-09-01
Est. Completion 2028-03

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT03402139

The ClinicalTrials.gov registry entry for NCT03402139 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 551-participant average among 43 other Childhood Obesity trials with a reported enrollment target (27% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Childhood Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT03402139 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03402139 about?

NCT03402139 is a clinical study titled "Early Childhood Obesity Programming by Intrauterine Growth Restriction". The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased ri...

What is the current status of trial NCT03402139?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2018-09-01. Estimated completion is 2028-03.

What conditions does trial NCT03402139 study?

This clinical trial studies the following conditions: Childhood Obesity, Epigenetics.

Who is sponsoring clinical trial NCT03402139?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03402139 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.